The acquisition of EUROLyser GmbH marks the pan-European private equity healthcare specialist’s second investment in the In-Vitro-Diagnostic sector this year, following the May purchase of Italy-based Diesse. ArchiMed’s latest deal signals its deepening interest in doing deals in the German-speaking region of Europe.
Merger and rebrand of three of the UK’s leading healthcare providers to form Vita Health Group ArchiMed, European private equity healthcare specialist, announces rebranding of its portfolio company, RehabWorks. The text below is an extract of Vita Health Group Announcement. Important Annoucement: Merger and rebrand of three of the UK’s leading healthcare providers to form a…
ArchiMed, European private equity healthcare specialist, announces full digitalisation of its portfolio company, Italian dental clinics company Primo. The digital transformation undertaken by Primo has enabled the company to upgrade to a modern, efficient and professional network of dental clinics and to a cutting edge innovative laboratory. Primo’s technological shift clearly aims at maintaining a…
ArchiMed acquires In Vitro Diagnostics specialist in cross-border carve-out The acquisition marks the pan-European healthcare private equity specialist’s second cross-border corporate carve-out in less than three months. Similar deals are expected to follow. May 22, 2019 – ArchiMed announces the purchase of Diesse Diagnostica Senese SpA (‘Diesse’) by Duomodiag Sarl, a holding company backed by ArchiMed…
Vita Health is the successful bidder for the delivery of the Bristol, North Somerset, South Gloucestershire IAPT services following a comprehensive procurement process that concluded in April 2019. As of September this year, Vita Health will be providing a redesigned and more comprehensive local service for patients. As well as continuing to provide high quality…
ArchiMed take-private bid for Bomi Group concludes successfully ArchiMed brings the take-private strategy to the mid-cap market with its acquisition. The pan-European healthcare private equity specialist expects to execute other take-private deals. May 14, 2019 – Following the May 10 close of the official bid period mandated by Italian stock market regulator CONSOB, ArchiMed announces that…